Showing results (591-600 of 722) with videos related to

Sort By:
Pageof 73
American Heart Journal|August 10, 2016
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trialCyril Camaro, Sander A J Damen, Marc A Brouwer, et al.
Journal of Electrocardiology|December 21, 2010
Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCITon Heestermans, Harry Suryapranata, Jurriën M ten Berg, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on ageAmber M Otten, Angela H E M Maas, Jan Paul Ottervanger, et al.
Osteoarthritis and Cartilage|March 10, 2026
PAR2 deletion in the osteoblast lineage affords long-term cartilage protection in experimental osteoarthritisC Huesa, S McGrath, L Dunning, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 10, 2024
2023 European Society of Cardiology guidelines for the management of acute coronary syndromes : Statement of endorsement by the NVVCBastiaan Zwart, Bimmer E P M Claessen, Peter Damman, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 14, 2011
The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCIRenicus S Hermanides, J Wouter van Werkum, Jan Paul Ottervanger, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 21, 2013
Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trialErik A Badings, Salem H K The, Jan-Henk E Dambrink, et al.
JACC. Cardiovascular Interventions|May 23, 2016
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers RegistryPier Woudstra, Deborah N Kalkman, Peter den Heijer, et al.
JMIR Cardio|October 17, 2022
Digital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER ConsortiumBart Scheenstra, Anke Bruninx, Florian van Daalen, et al.
Open Heart|January 28, 2025
Parsimonious versus extensive bleeding score: can we simplify risk stratification after percutaneous coronary intervention and reduce bleeding events by de-escalation of the antiplatelet strategy?Eva Christine Ida Woelders, Yoshinobu Onuma, Kai Ninomiya, et al.
Pageof 73